Biodesix

$19.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (+0.50%) As of 7:52 PM UTC today

Why Robinhood?

You can buy or sell Biodesix and other stocks, options, and ETFs commission-free!

About BDSX

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer.

CEO
Scott Hutton
Employees
200
Headquarters
Boulder, Colorado
Founded
2005
Market Cap
506.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
69.72K
High Today
$19.30
Low Today
$18.66
Open Price
$19.04
Volume
12.76K
52 Week High
$31.99
52 Week Low
$10.85

BDSX Earnings

-$31.93
-$21.29
-$10.64
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

GMBTU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure